A
AceCann
Biotech & Life Sciences · Lisbon, Portugal · Founded 2019
A medical cannabis company focused on the cultivation, processing, extraction and R&D of organic medical cannabis MoreLess
AceCann is a pioneering medical cannabis company based in Europe, specializing in the organic cultivation, processing, and extraction of high-quality cannabis products. The company operates in the rapidly growing medical cannabis market, focusing on providing premium products that meet stringent pharmaceutical standards. AceCann's mission is to improve lives by developing sustainable and innovative medical cannabis solutions, aiming to help patients live healthier and longer lives.
AceCann serves a diverse range of clients, primarily targeting patients who require medical cannabis for various health conditions. The company leverages its expertise in pharmaceutical practices to ensure that its products are consistent, safe, and effective. By adhering to Good Agricultural and Collection Practices (GACP) and European Union Good Manufacturing Practices (EU GMP), AceCann ensures that its cultivation and processing methods meet the highest quality standards.
The business model of AceCann revolves around three core activities: cultivation, processing, and extraction. The company uses proven organic cultivation techniques in a custom-engineered indoor facility to produce high-quality cannabis flowers. These flowers are then processed in an EU GMP-certified facility, designed and managed by a team with extensive pharmaceutical expertise. AceCann's unique solvent-free extraction technology maximizes the cannabinoid and terpene content, setting it apart from competitors in the European market.
AceCann generates revenue by selling its premium medical cannabis products to healthcare providers, pharmacies, and directly to patients through various distribution channels. The company also invests in research and development (R&D) to innovate and expand its product offerings, aiming to develop additional applications for medical cannabis.
In summary, AceCann is a leading European medical cannabis company dedicated to producing high-quality, sustainable, and innovative cannabis products. Its focus on organic cultivation, stringent processing standards, and unique extraction methods positions it as a key player in the medical cannabis market.
Keywords: Medical Cannabis, Organic Cultivation, EU GMP, Solvent-Free Extraction, Pharmaceutical Standards, Innovation, Sustainable Development, European Market, High-Quality Products, Healthcare.
Company overview
AceCann company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Lisbon, Portugal
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 84.3
Valuation & funding
AceCann funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2021 | $15M | $60M | Casa Verde Capital · Lince Capital | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
AceCann website traffic
Latest recorded traffic for AceCann is 320 monthly website visits, down 36% over the last three months. AceCann's team grew 23.5% over the past year.
Comparisons
AceCann compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
AceCann's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on AceCann's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where AceCann has talent and traffic
team presence
In the news
Latest news about AceCann
Recent press, funding announcements, and product moves mentioning AceCann — open to read from the original sources.
Market sentiment
What the market is saying about AceCann
An AI-synthesized read of the highest-engagement posts about AceCann on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AceCann’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.